Tenet Healthcare Reports Strong Q4 2025 Results with Revenue Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 11 2026
0mins
Should l Buy THC?
Source: Businesswire
- Significant Revenue Growth: In Q4 2025, Tenet Healthcare reported net operating revenues of $5.527 billion, an 8.9% increase from $5.073 billion in Q4 2024, indicating strong demand in acute care and ambulatory surgical services, thereby enhancing its competitive position in the market.
- Net Income Performance: The company achieved a net income of $371 million in Q4 2025, up 16.7% from $318 million in the same quarter last year, reflecting improved operational efficiency and effective cost control, which is expected to positively impact future shareholder returns.
- Adjusted EBITDA Growth: The adjusted EBITDA for Q4 reached $1.183 billion, a 12.8% increase from $1.048 billion in Q4 2024, indicating ongoing improvements in profitability across all business segments, which will support the achievement of financial targets for 2026.
- Optimistic 2026 Outlook: Tenet projects net operating revenues for 2026 to be between $21.5 billion and $22.3 billion, with adjusted EBITDA expected to reach between $4.485 billion and $4.785 billion, demonstrating the company's confidence in future growth and plans to enhance service quality and market share through continued investment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy THC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on THC
Wall Street analysts forecast THC stock price to rise
10 Analyst Rating
10 Buy
0 Hold
0 Sell
Strong Buy
Current: 240.590
Low
229.00
Averages
242.89
High
260.00
Current: 240.590
Low
229.00
Averages
242.89
High
260.00
About THC
Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The Company's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. It also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The Company operates a Global Business Center in the Philippines.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Positive Market News: Despite recent negative headlines regarding Iran, oil prices, market losses, and poor job numbers, there is encouraging news in the financial sector.
High-Performing Funds: Five investment funds are currently performing exceptionally well, providing a bright spot in an otherwise challenging economic landscape.
See More
- Weak Job Market: The U.S. nonfarm payrolls unexpectedly fell by 92,000 in February, significantly below the forecast of 50,000 and down from the revised January total of 126,000, indicating ongoing economic pressure from severe winter weather and a strike in the healthcare sector.
- Rising Unemployment Rate: The unemployment rate increased to 4.4%, reflecting job losses across key sectors, although a broader measure of unemployment, which includes discouraged workers and part-time workers for economic reasons, decreased to 7.9%, suggesting some resilience in the labor market.
- Wage Growth Exceeds Expectations: Despite the weak job data, average hourly earnings rose by 0.4% for the month and 3.8% year-over-year, both exceeding forecasts by 0.1 percentage points, indicating persistent labor cost pressures that could influence future monetary policy decisions.
- Significant Industry Impact: The healthcare sector lost 28,000 jobs due to the Kaiser Permanente strike, while information services and manufacturing saw declines of 11,000 and 12,000 jobs respectively, highlighting structural challenges within industries that may lead policymakers to adopt a more cautious approach in response to economic slowdown.
See More
- Job Growth Overview: According to the ADP report, the private sector added a seasonally adjusted 63,000 jobs in February, a significant improvement from the revised 11,000 in January and surpassing the Dow Jones estimate of 48,000, indicating resilience in the labor market.
- Sector Contribution Analysis: The education and health services sector led job creation with 58,000 new positions, while construction added 19,000, although most other sectors showed stagnant growth, highlighting the breadth issue in employment gains.
- Wage Growth Trends: Wage growth for job stayers remained steady at 4.5%, while the increase for job switchers fell to 6.3%, indicating that the incentive to change jobs has dropped to the lowest level since ADP began tracking this metric, potentially affecting future job mobility.
- Small Business Performance: Job gains were primarily concentrated in small businesses with fewer than 50 employees, which added 60,000 jobs, while large firms (500 or more employees) only added 10,000, reflecting the relative dynamism of small businesses in the current economic environment.
See More
- Strong Earnings Report: Tenet Healthcare reported $5.5 billion in revenue for Q4 2025, reflecting approximately 14% year-over-year growth and exceeding market expectations by $60 million, driven by favorable payer mix and increased disease severity.
- Improved Profitability: The company's non-GAAP EPS rose to $4.70, a 37% increase year-over-year, beating Wall Street forecasts by $0.65, with adjusted EBITDA margin reaching 21.4%, up 70 basis points from the previous year, indicating significant profitability enhancement.
- Positive Market Reaction: Tenet's stock surged nearly 19% on Wednesday, reaching an all-time high, which also boosted shares of major competitors like HCA Healthcare and Universal Health Services, reflecting strong market confidence in its financial performance.
- Future Outlook: Despite projecting a 20% decline in overall enrollments for 2026, Tenet anticipates net operating revenue of $21.9 billion, indicating approximately 4% year-over-year growth, showcasing the company's resilience and market confidence amid challenges.
See More
- Revenue and EBITDA Growth: Tenet Healthcare reported net operating revenues of $21.3 billion and consolidated adjusted EBITDA of $4.57 billion for 2025, reflecting a 14% increase over 2024 and exceeding initial expectations by nearly $500 million, indicating strong financial performance and market demand.
- Strong USPI Performance: The USPI segment achieved a 12% growth in adjusted EBITDA to $2.026 billion in 2025, with double-digit same-store volume growth in total joint replacements, demonstrating the company's sustained competitiveness in the healthcare services sector.
- Share Repurchase Program: Over the past three years, Tenet has repurchased approximately 22% of its outstanding shares for around $2.5 billion, reflecting the company's confidence in its value and creating additional value for shareholders.
- 2026 Guidance: Management projects adjusted EBITDA for 2026 to be between $4.485 billion and $4.785 billion, despite facing a $250 million impact from the expiration of tax credits, indicating a commitment to growth through ongoing M&A and service line expansion.
See More
- Earnings Beat: Diodes reported an adjusted EPS of 34 cents, surpassing market expectations of 32 cents, indicating strong profitability that boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $391.578 million, exceeding the anticipated $385.560 million, suggesting sustained demand for its products that could drive future revenue growth.
- Stock Surge: Diodes shares jumped 31.8% to $81.32 on Wednesday, reflecting a positive market reaction to its earnings report, which may attract more investor interest.
- Market Performance: U.S. stocks were slightly higher, with the Dow Jones gaining around 0.1% on Wednesday, indicating cautious optimism about the economic outlook that could provide a favorable environment for other companies.
See More











